 "Unichem Lab near record high on talks of Torrent Pharma eyeing domestic biz")
Unichem Laboratories was trading 3% higher at Rs 315, extending its past two days 17% surge on the BSE, as media reports suggest that Torrent Pharma is in advanced talks to buy the company’s domestic business.
The stock of Unichem Laboratories hit a fresh 52-week high of Rs 323 on the BSE in early morning trade. It is trading close to its record high of Rs 334 touched on October 6, 2015 in intra-day trade.
The trading volumes on the counter more than doubled with a combined 837,972 shares changed hands on the BSE and NSE till 12:45 PM.
The BSE said the exchange has sought clarification from Unichem Laboratories Ltd on October 30, 2017, with reference to news in www.moneycontrol.com dated October 27, 2017 quoting "Torrent Pharma in talks to buy Unichem's domestic business". The reply is awaited.
Torrent Pharmaceuticals was up 1% at Rs 1,277, after hitting intra-day high of Rs 1,282 on the BSE.
The stock of Unichem Laboratories hit a fresh 52-week high of Rs 323 on the BSE in early morning trade. It is trading close to its record high of Rs 334 touched on October 6, 2015 in intra-day trade.
The trading volumes on the counter more than doubled with a combined 837,972 shares changed hands on the BSE and NSE till 12:45 PM.
The BSE said the exchange has sought clarification from Unichem Laboratories Ltd on October 30, 2017, with reference to news in www.moneycontrol.com dated October 27, 2017 quoting "Torrent Pharma in talks to buy Unichem's domestic business". The reply is awaited.
Torrent Pharmaceuticals was up 1% at Rs 1,277, after hitting intra-day high of Rs 1,282 on the BSE.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%